Cargando…

Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals

This cross-sectional study assesses the availability of the direct oral anticoagulant reversal agents idarucizumab and andexanet alfa in US hospitals.

Detalles Bibliográficos
Autores principales:	Kanjee, Zahir, McCann, Marissa L., Freed, Jason A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122227/ https://www.ncbi.nlm.nih.gov/pubmed/33988710 http://dx.doi.org/10.1001/jamanetworkopen.2021.10079

Ejemplares similares

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Oral available agents in the treatment of RRMS
por: Aupérin, Thierry
Publicado: (2013)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study
por: Samaranayake, Chinthaka B., et al.
Publicado: (2021)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

The Reversal of Direct Oral Anticoagulants in Animal Models
por: Honickel, Markus, et al.
Publicado: (2017)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis
por: Chaudhary, Rahul, et al.
Publicado: (2022)

Direct oral anticoagulant use in left ventricular thrombus
por: Ali, Zafar, et al.
Publicado: (2020)

Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
por: Brown, Karen S., et al.
Publicado: (2016)

Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

More Smart Use of Direct Oral Anticoagulants in Geriatric Patients [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2023)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015
por: Feistritzer, Clemens, et al.
Publicado: (2016)

Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
por: Dabi, Alok, et al.
Publicado: (2018)

Pharmacological reversal of the direct oral anticoagulants—A comprehensive review of the literature
por: Shaw, Joseph R., et al.
Publicado: (2018)

A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
por: Joppa, Stephanie A., et al.
Publicado: (2018)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients
por: Barbui, Tiziano, et al.
Publicado: (2021)

Specific reversal agents: Fast and fearless – A new era in anticoagulation care
por: Bhave, Abhay
Publicado: (2019)

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
por: Lessire, Sarah, et al.
Publicado: (2016)

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)

Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach
por: Dawson, Taylor, et al.
Publicado: (2020)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents
por: Ahmed, Zaheer, et al.
Publicado: (2016)

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019
por: Troy, Aaron, et al.
Publicado: (2021)

Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
por: Giugliano, Robert P., et al.
Publicado: (2021)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis
por: Rozi, Waail, et al.
Publicado: (2022)

Teaching Evidence-Based Physical Diagnosis: A Workshop for Hospitalists
por: Kanjee, Zahir, et al.
Publicado: (2022)

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
por: Pyykönen, Mikko, et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h036drvnepem9lbaoumd5gqb2t